AZmed vs Milvue (2026)

AI Health Index verifiedJuly 22, 2026
Verdict

Both read plain radiographs for trauma and chest, both are FDA cleared and assistive, and both come from Paris, so the split is detection breadth against measurement and reporting. AZmed's Rayvolve covers fractures, dislocations and joint effusions across the limbs, pelvis, hip, spine and ribs in adults and children aged two and over, with clearances resting on studies at University Hospitals Cleveland and SimonMed and a 2026 analysis of 258,373 X-rays across 26 countries. Milvue pairs detection, cleared for fractures from birth onward, with about 60 automatic bone measurements and a pre filled report returned in under 30 seconds, runs on premises or in the cloud, and publishes fracture results by age band, sex, manufacturer and anatomical region. If your failure mode is trauma detection across fractures, dislocations and effusions in one product, start with AZmed. If it is detection, measurement and reporting in one tool, or keeping imaging inside the hospital, start with Milvue.

The case for AZmed
  • One cleared product covers fractures, dislocations and joint effusions across the limbs, pelvis, hip, spine and ribs, in adults and children aged two and over.
  • Its validation spans many sites, including studies at University Hospitals Cleveland and SimonMed and a 2026 multicenter analysis of 258,373 X-rays from 100 centers in 26 countries.
  • Its 2026 FDA summary reports results by region and finding, with sensitivity from 96.1 percent at the thoracic spine to 97.8 percent at the ribs.
The case for Milvue
  • Detection and measurement come in one tool, with about 60 automatic bone measurements, including bone age, EOS and Cobb angles, beside fracture and chest detection.
  • It runs on premises or in the cloud, and TechCare Report pre fills the radiology report in under 30 seconds, labeled as software that is not a medical device.
  • Its FDA summary publishes fracture results by age band, sex, imaging manufacturer and anatomical region, from 0.893 at the adult pelvis to 0.998 at the clavicle, so the weak spots are visible.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AZmed and Milvue are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact AZmed Milvue
Primary category Radiology & Imaging AI Radiology & Imaging AI
Founded 2018 2018
Headquarters Paris, France Paris, France
Website azmed.co milvue.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
A
AZmed
M
Milvue
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Change Log

Product updates

The latest logged changes from each vendor, newest first, each linked to its source.

AZmed

  • Clinical evidence

    CHU de Reims, which has used AZmed's fracture detection on all patients since 2021, published an independent evaluation in Pediatric Radiology.

    Source
  • Regulatory / FDA

    AZmed received its sixth FDA clearance, for AZchest to detect and localize pneumothorax and pleural effusion on chest radiographs.

    Source
All 2 AZmed updates →

Milvue

  • Clinical evidence

    A retrospective single-center study published in Diagnostics externally validated several CE-certified AI systems, including Milvue's TechCare Kids, for automated bone age assessment.

    Source
All 1 Milvue update →
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.

AZmed

Paris based imaging AI company whose Rayvolve suite reads plain radiographs: AZtrauma detects fractures, dislocations and joint effusions, AZchest covers chest findings including pneumothorax, pleural effusion and lung nodules, and AZmeasure and AZboneage add measurements and bone age. A second suite, Rayscan, detects lung nodules on CT.

Source: AI Health Index, July 2026

Milvue

French imaging AI company based in Paris whose Milvue Suite reads plain radiographs. TechCare Alert detects fractures, dislocations, joint effusions, pneumothorax and nodules; TechCare Metrics returns about 60 automated bone measurements, including lower limbs, EOS, bone age and Cobb angles; and TechCare Report pre-fills the radiology report, which the company labels as not a medical device, with results returned in under 30 seconds.

Source: AI Health Index, July 2026

FAQ

Questions buyers ask

How do AZmed and Milvue work with the EHR?

For AZmed, the company reports use at more than 2,500 sites in more than 55 countries and 15.4 million X-rays analyzed in the last twelve months, and its clearances rested on studies at named US institutions, University Hospitals in Cleveland and SimonMed Imaging. It has also been distributed through third party cloud radiology workflow platforms, including RADIN.

Milvue is also listed in the Blackford Analysis imaging AI portfolio, a named orchestration platform that gives a second route into an existing workflow. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.

How are AZmed and Milvue priced and sold?

In AZmed's case, the software has been sold both directly and through cloud radiology platforms. The company's scale figures, more than 2,500 sites in more than 55 countries, describe use, not price.

For Milvue, the module structure is public, though. TechCare Alert handles detection, TechCare Metrics handles measurements and TechCare Report produces the prefilled report, and the three carry different regulatory status. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.

How do AZmed and Milvue handle patient data?

With AZmed, the home page describes SOC 2, GDPR and HIPAA compliant infrastructure. The privacy policy, approved in December 2025, covers the website, billing, prospecting and recruitment, with retention periods for those records only; it does not address images or outputs processed by Rayvolve or Rayscan.

In Milvue's case, the TechCare Trauma 510(k) summary (K242171) states that the software is deployed on premises or in the cloud; a hospital that runs it on premises keeps its studies inside its own systems, which removes most of the retention and secondary use question for that site. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.

What evidence is published for AZmed and Milvue?

For AZmed, a 2026 multicenter analysis by Cohen and colleagues covers 258,373 X-rays from 100 centers in 26 countries.

With Milvue, the number of readers is not stated. Standalone tests used 4,109 adult and 2,872 pediatric radiographs from at least four US states and fourteen equipment makers, against a reference of three board certified radiologists per case. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.

Disclosure

Neither vendor publishes a price, a security attestation of its own or business associate terms; AZmed calls its infrastructure SOC 2 compliant without naming whose report it is, and Milvue's privacy policy covers only its website. Neither names a hosting region for its cloud option.

AZmed's 99.7 percent negative predictive value carries no method, and Milvue's claim of an area under the curve above 96 percent across all ages is contradicted by its own summary's figures for infants and patients 65 and over. An earlier version of this comparison said Milvue's headline figure is not broken out by pathology, region or age; its FDA summary breaks it out by region, age band, sex and manufacturer. That statement was corrected on 10 October 2026.